There’s still a few days left to submit your letter of intent for the Translational Research Program (TRP) offered by the Leukemia & Lymphoma Society.

Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of leukemia, lymphoma and myeloma. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The program is intended to cover an initial three year period (with two year renewal) and will provide support for work which is clinical in orientation with an overall goal to result in a clinical trial and/or TRP renewal.

Letters of intent are due by 3:00 pm on February 17, 2015. For more information, see the TRP Guidelines & Instructions for fiscal year 2015.